|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/04 | |
| C07B 59/00 | |||
| A61K 31/519 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2536727 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11704225.9 |
| Europos patento paraiškos padavimo data | 2011-02-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-12-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-07-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2011/052365 |
| Data | 2011-02-17 |
| (87) | Numeris | WO 2011/101417 |
| Data | 2011-08-25 |
| (30) | Numeris | Data | Šalis |
| 306248 P | 2010-02-19 | US |
| (72) |
BRAIN, Christopher Thomas, US
PEREZ, Lawrence Blas, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | DEUTERATED PYRROLOPYRIMIDINE COMPOUNDS AS INHIBITORS OF CDK4/6 |
| DEUTERATED PYRROLOPYRIMIDINE COMPOUNDS AS INHIBITORS OF CDK4/6 |